Rare Variants in PFIC‐Related Genes Among Adults With Intrahepatic Cholestasis
Hepatology Research · 2026-11 · 56 (11) · 1749-1753
DOI: 10.1111/hepr.70229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hepatology Research, online erschienen am 20.06.2026. Verfasst von Shunji Hirose und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, and Technology, Japan.
Abstract (Originalsprache)
Aim
Biallelic pathogenic variants in progressive familial intrahepatic cholestasis (PFIC)‐related genes cause severe pediatric cholestasis. However, the clinical significance of heterozygous variants in adult intrahepatic cholestasis remains unclear. We investigated the prevalence of heterozygous PFIC‐related gene variants in Japanese adults with intrahepatic cholestasis.
Methods
Whole‐exome sequencing was performed in 19 adults diagnosed with intrahepatic cholestasis. Rare variants (allele frequency ≤ 0.01 in the Japanese population) predicted to be functionally damaging by in silico tools were extracted and classified according to ACMG/AMP guidelines. Allele frequencies were compared with the GEM Japan whole genome aggregation database.
Results
Four heterozygous variants in PFIC‐related genes were identified in four patients (21%), and all variant carriers were diagnosed with drug‐induced liver injury. One patient carried a known pathogenic ABCB11 splice‐site variant (c.908+1G>A), which was extremely rare in the Japanese reference population. The remaining variants were predicted to be functionally damaging by in silico analyses but were classified as variants of uncertain significance by ACMG criteria.
Conclusions
Rare variants in PFIC‐related genes were identified in a subset of adults with intrahepatic cholestasis. Although all variant carriers were diagnosed with drug‐induced liver injury, the clinical significance of these variants remains uncertain, particularly because most were classified as variants of uncertain significance. These findings should be considered exploratory and hypothesis‐generating.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
- Support Center for Medical Research and Education, Tokai University, Isehara, Kanagawa, Japan.
ORCID-Profile: Kota Tsuruya, Sanae Isaki, Tatehiro Kagawa
Förderung
- Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, and Technology, Japan
Zitieren
APA
Hirose, S., Tsuruya, K., Mishima, Y., Arase, Y., Shiraishi, K., Hao, V. T., Ieda, S., Tanaka, M., Isaki, S., & Kagawa, T. (2026). Rare Variants in PFIC‐Related Genes Among Adults With Intrahepatic Cholestasis. Hepatology Research, 56(11), 1749-1753. https://doi.org/10.1111/hepr.70229
Vancouver
Hirose S, Tsuruya K, Mishima Y, Arase Y, Shiraishi K, Hao VT, et al. Rare Variants in PFIC‐Related Genes Among Adults With Intrahepatic Cholestasis. Hepatology Research. 2026;56(11):1749-1753. doi:10.1111/hepr.70229
BibTeX
@article{Hirose2026,
author = {Hirose, Shunji and Tsuruya, Kota and Mishima, Yusuke and Arase, Yoshitaka and Shiraishi, Koichi and Hao, Vu Thi and Ieda, Satsuki and Tanaka, Masayuki and Isaki, Sanae and Kagawa, Tatehiro},
title = {Rare Variants in PFIC‐Related Genes Among Adults With Intrahepatic Cholestasis},
journal = {Hepatology Research},
year = {2026},
volume = {56},
number = {11},
pages = {1749--1753},
doi = {10.1111/hepr.70229}
}
EUVIMED